Dexilant
dexlansoprazole
- Strength
- 60 mg/1
- Form
- Capsule, Delayed Release
- Class
- Proton Pump Inhibitor
Takeda Pharmaceuticals America, Inc.
Listed by Alembic Pharmaceuticals Inc.
| Dosage form | Capsule, Delayed Release |
|---|---|
| Route | Oral |
| Drug class | Proton Pump Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 62332-824 |
| FDA application | ANDA219115 |
| RxNorm concept | 833204 |
| Package sizes listed | 2 |
| Marketed since | November 2025 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
dexlansoprazole
Takeda Pharmaceuticals America, Inc.
dexlansoprazole
Takeda Pharmaceuticals America, Inc.
Par Health USA, LLC
Alembic Pharmaceuticals Limited
A-S Medication Solutions
Alembic Pharmaceuticals Inc.
Bryant Ranch Prepack
Par Health USA, LLC
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.